Volume 23, No 4, Apr 2013
ISSN: 1001-0602
EISSN: 1748-7838 2018
impact factor 17.848*
(Clarivate Analytics, 2019)
Volume 23 Issue 4, April 2013: 577-580
LETTERS TO THE EDITOR
Monoclonal antibody against CXCL-10/IP-10 ameliorates influenza A (H1N1) virus induced acute lung injury
Wei Wang1,*, Penghui Yang2,3,*, Ying Zhong1,*, Zhongpeng Zhao2, Li Xing2, Yan Zhao1, Zhen Zou1, Yanli Zhang1, Chenggang Li1, Taisheng Li4, Chen Wang5,6, Zhong Wang4, Xuezhong Yu4, Bin Cao6, Xiang Gao7, Josef M Penninger8, Xiliang Wang2 and Chengyu Jiang1,4
1State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Department of Biochemistry and Molecular Biology, Peking Union Medical College, Tsinghua University, Beijing 100005, China
2State Key Laboratory of Pathogens and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China
3Department of Hepatobiliary, 302 Military Hospital, Beijing 100039, China
4Center for Translational Medicine, Peking Union Medical College Hospital, Beijing 100730, China
5Beijing Hospital, China Ministry of Health, Beijing 100730, China
6Beijing Chao-Yang Hospital, Beijing Institute of Respiratory Medicine, Capital Medical University, Beijing 100020, China
7MOE key laboratory of Model Animal for Disease Study, Model Animal Research Center of Nanjing University, Nanjing, Jiangsu 210061, China
8Institute of Molecular Biotechnology in the Austrian Academy of Sciences, Vienna A-1030, Austria
Correspondence: Chengyu Jiang, Xiliang Wang(jiang@pumc.edu.cn; xiliangw@126.com)
Cell Research (2013) 23:577–580. doi:10.1038/cr.2013.25; published online 19 February 2013
FULL TEXT | PDF
Browse 2299